Advances in imaging diagnosis of small hepatocellular carcinoma

World Chinese Journal of Digestology

Volumn 18, Issue 5, 2010, Pages 479-486

  Qian, Lin Xue ^a   Liu, Yu Jiang ^a   Ding, Hui Guo ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Contrastenhanced ultrasonography; Digital subtraction angiography; Hepatocellular carcinoma; Magnetic resonance imaging; Small hepatocellular carcinoma; Ultrasound; X ray computed tomography

Indexed keywords

ALCOHOL; CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOXETIC ACID; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

CANCER DIAGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CATHETER ABLATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISTRESS SYNDROME; HUMAN; IMAGE ENHANCEMENT; LIVER CELL CARCINOMA; PATIENT SELECTION; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT;

EID: 77749317429     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v18.i5.479     Document Type: Review

References (45)

1. Golfieri R, Marini E, Bazzocchi A, Fusco F, Trevisani F, Sama C, Mazzella G, Cavuto S, Piscaglia F, Bolondi L. Small (
2. Zender L, Xue W, Cordón-Cardo C, Hannon GJ, Lucito R, Powers S, Flemming P, Spector MS, Lowe SW. Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors. Cold Spring Harb Symp Quant Biol 2005; 70: 251-261
3. Volk ML, Marrero JA. Early detection of liver cancer: diagnos is and management . Curr Gastroenterol Rep 2008; 10: 60-66
4. Chinese source
5. Takayama T, Makuuchi M, Kojiro M, Lauwers GY, Adams RB, Wilson SR, Jang HJ, Charnsangavej C, Taouli B. Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol 2008; 15: 972-978
6. Chinese source
7. Taj ima T, Honda H, Taguchi K, Asayama Y, Kuroiwa T, Yoshimitsu K, Irie H, Aibe H, Shimada M, Masuda K. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 2002; 178: 885-897
8. Chinese source
9. Chinese source
10. Luca A, Caruso S, Milazzo M, Mamone G, Marrone G, Miraglia R, Maruzzelli L, Carollo V, Minervini MI , Vizzini G, Grutttadaur ia S, Gridelli B. Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants. Eur Radiol 2009 Oct 3. [Epub ahead of print]
11. Chinese source
12. Kudo M. Early detection and curative treatment of early-stage hepatocellular carcinoma. Clin Gastroenterol Hepatol 2005; 3: S144-S148
13. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3: 353-367
14. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubbleenhanced US. Radiographics 2004; 24: 921-935
15. Chinese source
16. Chinese source
17. Chinese source
18. Wi lson SR, Burns PN. An algor i thm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 2006; 186: 1401-1412
19. Burns PN, Wi l son SR. Focal liver masses: enhancement pat terns on contrast-enhanced images - concordance of US scans with CT scans and MR images. Radiology 2007; 242: 162-174
20. Chinese source
21. Chinese source
22. Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, Tsuda K, Osuga K, Kawata S, Nakamura H, Kudo M. Hypervascular hepatocellular carcinoma: detection with double arterial phase multidetector row helical CT. Radiology 2001; 218: 763-767
23. Zhao H, Yao JL, Wang Y, Zhou KR. Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning. World J Gastroenterol 2007; 13: 1252-1256
24. Chinese source
25. Chinese source
26. Chinese source
27. Chinese source
28. Amano S, Ebara M, Yajima T, Fukuda H, Yoshikawa M, Sugiura N, Kato K, Kondo F, Matsumoto T, Saisho H. Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2003; 18: 273-279
29. Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, Francis IR. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 2004; 230: 637-644
30. Chinese source
31. Saar B, Kellner-Weldon F. Radiological diagnosis of hepatocellular carcinoma. Liver Int 2008; 28: 189-199
32. Lauenstein TC, Salman K, Morreira R, Heffron T, Spivey JR, Martinez E, Sharma P, Martin DR. Gadolinium-enhanced MRI for tumor surveillance before l iver t ransplantat ion: center -based experience. AJR Am J Roentgenol 2007; 189: 663-670
33. Chinese source
34. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998; 170: 397-402
35. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003; 226: 71-78
36. Kim YK, Kim CS, Kwak HS, Lee JM. Threedimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging. J Magn Reson Imaging 2004; 20: 826-837
37. Yoshioka H, Takahashi N, Yamaguchi M, Lou D, Saida Y, Itai Y. Double arterial phase dynamic MRI wi th sensi t ivi ty encoding (SENSE) for hypervascular hepatocellular carcinomas. J Magn Reson Imaging 2002; 16: 259-266
38. Chinese source
39. Chinese source
40. Khan MA, Combs CS, Brunt EM, Lowe VJ , Wolverson MK, Solomon H, Collins BT, Di Bisceglie AM. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000; 32: 792-797
41. Chinese source
42. Chinese source
43. Chinese source
44. McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, Dunaway E, Williams J. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000; 32: 842-846
45. Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol 2005; 20: 873-881